| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |